ATI Elimination Comprehensive Assessment Exam Prep
Document | 2026/2027 Edition | 250 Verified Questions
ATI Elimination Comprehensive Assessment 2026-2027 QUESTIONS AND ANSWERS
ALREADY GRADED A+. 100% Verified Solutions | Updated Per Latest NCLEX & ATI
Guidelines | Graded A+
This comprehensive exam prep document covers the ATI Elimination Comprehensive Assessment,
focusing on urinary and bowel elimination, renal function, and related nursing interventions. It
includes 250 verified questions with detailed rationales to enhance clinical judgment and NCLEX
readiness. Updated for the 2026/2027 academic year, this resource aligns with the latest ATI testing
standards and evidence-based practice. Ideal for nursing students seeking to master elimination
concepts and achieve high scores on their ATI assessments.
Key Features:
Urinary Elimination: Anatomy, physiology, and common disorders
Bowel Elimination: Constipation, diarrhea, ostomy care
Renal Function: Fluid and electrolyte balance, renal failure
Catheterization and Incontinence Management
Pharmacology: Diuretics, anticholinergics, laxatives
Diagnostic Tests: Urinalysis, BUN, creatinine, imaging
Updates for 2026:
- Incorporated 2026 NCLEX-RN test plan changes for elimination content
- Added new questions on catheter-associated urinary tract infection prevention
- Updated rationales to reflect latest evidence-based guidelines
- Included expanded coverage of bowel diversion procedures and care
- Revised pharmacology section with new drug classifications and interactions
Abstract:
This exam preparation document is meticulously designed for nursing students preparing for the ATI Elimination
Comprehensive Assessment, a critical component of the NCLEX readiness evaluation. The content encompasses a
thorough review of urinary and bowel elimination, including anatomy, physiology, pathophysiology, and nursing
management. Each of the 250 questions is accompanied by detailed rationales that explain correct and incorrect
answers, fostering clinical reasoning and application. The document is updated for the 2026/2027 academic year,
reflecting the latest ATI and NCLEX standards, and includes evidence-based practices for conditions such as
urinary tract infections, renal failure, constipation, and ostomy care. Emphasis is placed on pharmacological
interventions, diagnostic interpretation, and patient-centered care. This resource is essential for achieving a high
score on the ATI Elimination Assessment and strengthening overall nursing competency.
Keywords:
ATI Elimination Assessment, NCLEX readiness, urinary elimination, bowel elimination, renal function, catheter
care, ostomy management, pharmacology for elimination
Answer Format:
Each question is presented in multiple-choice format with four options. Detailed rationales explain why the correct
answer is right and why each distractor is wrong, including references to nursing concepts and evidence-based
practice. Rationales are structured to enhance clinical judgment and application to real-world scenarios.
Compliance Checklist:
Aligned with 2026/2027 ATI Elimination Comprehensive Assessment blueprint
Page 1
, Reflects latest NCLEX-RN test plan and clinical judgment model
Questions reviewed by subject matter experts for accuracy
Rationales cite current nursing textbooks and evidence-based guidelines
Covers all major content areas weighted per ATI specifications
Includes updated pharmacology and diagnostic test information
Content Area Overview:
Content Area Questions Key Topics Weight
Urinary Elimination 1-60 Anatomy of urinary system, urinalysis, 24%
urinary tract infections, incontinence,
catheterization
Bowel Elimination 61-120 Constipation, diarrhea, bowel diversion 24%
(colostomy/ileostomy), bowel training,
laxatives
Renal Function and 121-170 Acute/chronic renal failure, BUN/creatinine, 20%
Fluid/Electrolyte Balance fluid volume deficit/excess, electrolyte
imbalances
Pharmacology for Elimination 171-210 Diuretics, anticholinergics, laxatives, stool 16%
softeners, antibiotics for UTIs
Diagnostic Tests and Procedures 211-240 Cystoscopy, urodynamic studies, KUB, 12%
renal ultrasound, bowel imaging
Patient Education and Nursing 241-250 Promoting normal elimination, preventing 4%
Interventions complications, discharge teaching
Page 2
,Q1. A patient with a history of recurrent urinary tract infections (UTIs) is prescribed a prophylactic
antibiotic. Which of the following mechanisms best explains why nitrofurantoin is preferred over
trimethoprim-sulfamethoxazole for long-term prophylaxis in this population, considering the impact on gut
and vaginal flora?
A. Nitrofurantoin achieves high urinary concentrations but minimal systemic absorption, reducing disruption of
normal microbiota.
B. Trimethoprim-sulfamethoxazole has a longer half-life, requiring less frequent dosing, which improves
adherence.
C. Nitrofurantoin is more effective against gram-negative bacteria, the most common cause of UTIs.
D. Trimethoprim-sulfamethoxazole is associated with a higher risk of Clostridioides difficile infection due to
broader spectrum activity.
Correct Answer: A. Nitrofurantoin achieves high urinary concentrations but minimal systemic absorption,
reducing disruption of normal microbiota.
Rationale: Nitrofurantoin is well-absorbed orally but rapidly excreted into urine, achieving high urinary
concentrations with low tissue levels; this minimizes disruption of gut and vaginal flora, reducing the risk of
secondary infections like candidiasis and C. difficile. Trimethoprim-sulfamethoxazole, while effective, has broader
systemic absorption and can alter normal flora, increasing resistance and adverse effects. Option A directly
addresses the key pharmacological advantage for prophylaxis.
Why Wrong:
B - While TMP-SMX has a longer half-life, this does not mitigate its impact on flora; adherence is not the
primary concern for prophylaxis.
C - Nitrofurantoin is effective against many gram-negative and some gram-positive organisms, but its
advantage is not solely based on spectrum; both drugs cover common uropathogens.
D - C. difficile risk is a concern with many antibiotics, but TMP-SMX is not the highest risk; the main reason
for preferring nitrofurantoin is its pharmacokinetic profile, not avoidance of C. difficile specifically.
Reference: Lehne, R.A. (2026). Pharmacology for Nursing Care, 12th Ed., Ch. 82
Q2. In a patient with chronic kidney disease (CKD) stage 4 and hyperphosphatemia, which of the following
phosphate binder combinations would be most appropriate, considering the patient's serum calcium level of
9.0 mg/dL (normal 8.5-10.5) and intact parathyroid hormone (iPTH) of 300 pg/mL (normal 10-65)?
A. Calcium carbonate alone, because the serum calcium is normal and calcium-based binders are most
effective.
B. Sevelamer carbonate alone, because it avoids calcium loading and has additional lipid-lowering effects.
C. Lanthanum carbonate alone, because it is the most potent binder and does not require multiple tablets.
D. A combination of calcium acetate and sevelamer carbonate, to achieve target phosphate while minimizing
calcium load.
Correct Answer: D. A combination of calcium acetate and sevelamer carbonate, to achieve target phosphate
while minimizing calcium load.
Rationale: In CKD stage 4 with hyperphosphatemia and elevated iPTH, the goal is to reduce phosphate without
inducing hypercalcemia (which could suppress PTH excessively) or worsening vascular calcification.
Calcium-based binders are effective but can cause calcium overload; non-calcium binders like sevelamer avoid
this. Combining a calcium-based binder (e.g., calcium acetate) with sevelamer allows lower doses of each,
achieving phosphate control while limiting calcium intake. Lanthanum is potent but expensive and carries risk of
accumulation; monotherapy with any single agent may require high doses. Option D represents a balanced,
guideline-recommended approach.
Why Wrong:
B - Sevelamer alone may require high pill burden and does not provide calcium for patients with low calcium;
the patient's calcium is normal, but adding a calcium binder can help achieve phosphate targets with fewer
pills.
Page 3
, C - Lanthanum is effective but not first-line due to cost and long-term safety concerns; combination therapy is
often preferred.
Reference: KDOQI Clinical Practice Guidelines for Bone Metabolism and Disease in CKD (2023)
Q3. A patient with neurogenic bladder due to spinal cord injury is started on clean intermittent
catheterization (CIC). Which of the following interventions is most critical to prevent autonomic dysreflexia
during catheterization?
A. Use a smaller catheter size (10-12 Fr) to minimize urethral trauma.
B. Instill 2% lidocaine gel into the urethra 5 minutes before catheterization.
C. Ensure the bladder is drained completely and slowly to avoid rapid decompression.
D. Perform catheterization at scheduled times to maintain bladder capacity.
Correct Answer: B. Instill 2% lidocaine gel into the urethra 5 minutes before catheterization.
Rationale: Autonomic dysreflexia (AD) is a life-threatening condition in patients with spinal cord injury above T6,
triggered by noxious stimuli below the level of injury, such as urethral distention or catheter insertion. Lidocaine
gel provides topical anesthesia, reducing afferent stimulation and preventing the reflex sympathetic surge. Smaller
catheters reduce trauma but do not eliminate the risk; slow drainage prevents hypotension but not AD; scheduled
catheterization helps with bladder management but does not directly prevent AD.
Why Wrong:
A - Smaller catheters reduce trauma but do not anesthetize the urethra; AD can still be triggered.
C - Rapid decompression can cause hypotension, not AD; AD is characterized by hypertension.
D - Scheduled CIC is important for bladder health but does not prevent AD; anesthesia is key.
Reference: Consortium for Spinal Cord Medicine. (2021). Clinical Practice Guideline: Management of Autonomic
Dysreflexia.
Q4. Which of the following laboratory findings is most consistent with prerenal acute kidney injury (AKI) as
opposed to intrinsic renal AKI due to acute tubular necrosis (ATN)?
A. Urine sodium < 20 mEq/L and fractional excretion of sodium (FeNa) < 1%.
B. Urine osmolality < 350 mOsm/kg and urine sediment with muddy brown casts.
C. Serum BUN:creatinine ratio < 10:1 and urine specific gravity < 1.010.
D. Fractional excretion of urea (FeUrea) < 35% and urine sodium > 40 mEq/L.
Correct Answer: A. Urine sodium < 20 mEq/L and fractional excretion of sodium (FeNa) < 1%.
Rationale: Prerenal AKI results from decreased renal perfusion, leading to intact tubular function that avidly
reabsorbs sodium and water, resulting in low urine sodium (<20 mEq/L) and low FeNa (<1%). In ATN, tubular
damage impairs reabsorption, causing higher urine sodium (>40 mEq/L) and FeNa >2%. Option A is classic for
prerenal. Option B describes ATN (muddy brown casts, low osmolality). Option C suggests intrinsic disease.
Option D (low FeUrea <35%) can be seen in prerenal, but high urine sodium contradicts prerenal.
Why Wrong:
B - Muddy brown casts and low urine osmolality are characteristic of ATN, not prerenal.
C - Low BUN:creatinine ratio and low specific gravity suggest intrinsic renal disease, not prerenal.
D - FeUrea <35% can occur in prerenal, but urine sodium >40 mEq/L is more consistent with ATN; this
combination is atypical.
Reference: KDIGO Clinical Practice Guideline for Acute Kidney Injury (2022)
Q5. A patient with cirrhosis and ascites is being evaluated for spontaneous bacterial peritonitis (SBP). A
diagnostic paracentesis reveals a polymorphonuclear neutrophil (PMN) count of 350 cells/mm³. Which of the
following is the most appropriate next step in management?
A. Start empiric antibiotic therapy with cefotaxime and intravenous albumin.
B. Repeat paracentesis in 48 hours to confirm the diagnosis before starting antibiotics.
C. Obtain blood cultures and start empiric antibiotic therapy with ceftriaxone alone.
Page 4
Document | 2026/2027 Edition | 250 Verified Questions
ATI Elimination Comprehensive Assessment 2026-2027 QUESTIONS AND ANSWERS
ALREADY GRADED A+. 100% Verified Solutions | Updated Per Latest NCLEX & ATI
Guidelines | Graded A+
This comprehensive exam prep document covers the ATI Elimination Comprehensive Assessment,
focusing on urinary and bowel elimination, renal function, and related nursing interventions. It
includes 250 verified questions with detailed rationales to enhance clinical judgment and NCLEX
readiness. Updated for the 2026/2027 academic year, this resource aligns with the latest ATI testing
standards and evidence-based practice. Ideal for nursing students seeking to master elimination
concepts and achieve high scores on their ATI assessments.
Key Features:
Urinary Elimination: Anatomy, physiology, and common disorders
Bowel Elimination: Constipation, diarrhea, ostomy care
Renal Function: Fluid and electrolyte balance, renal failure
Catheterization and Incontinence Management
Pharmacology: Diuretics, anticholinergics, laxatives
Diagnostic Tests: Urinalysis, BUN, creatinine, imaging
Updates for 2026:
- Incorporated 2026 NCLEX-RN test plan changes for elimination content
- Added new questions on catheter-associated urinary tract infection prevention
- Updated rationales to reflect latest evidence-based guidelines
- Included expanded coverage of bowel diversion procedures and care
- Revised pharmacology section with new drug classifications and interactions
Abstract:
This exam preparation document is meticulously designed for nursing students preparing for the ATI Elimination
Comprehensive Assessment, a critical component of the NCLEX readiness evaluation. The content encompasses a
thorough review of urinary and bowel elimination, including anatomy, physiology, pathophysiology, and nursing
management. Each of the 250 questions is accompanied by detailed rationales that explain correct and incorrect
answers, fostering clinical reasoning and application. The document is updated for the 2026/2027 academic year,
reflecting the latest ATI and NCLEX standards, and includes evidence-based practices for conditions such as
urinary tract infections, renal failure, constipation, and ostomy care. Emphasis is placed on pharmacological
interventions, diagnostic interpretation, and patient-centered care. This resource is essential for achieving a high
score on the ATI Elimination Assessment and strengthening overall nursing competency.
Keywords:
ATI Elimination Assessment, NCLEX readiness, urinary elimination, bowel elimination, renal function, catheter
care, ostomy management, pharmacology for elimination
Answer Format:
Each question is presented in multiple-choice format with four options. Detailed rationales explain why the correct
answer is right and why each distractor is wrong, including references to nursing concepts and evidence-based
practice. Rationales are structured to enhance clinical judgment and application to real-world scenarios.
Compliance Checklist:
Aligned with 2026/2027 ATI Elimination Comprehensive Assessment blueprint
Page 1
, Reflects latest NCLEX-RN test plan and clinical judgment model
Questions reviewed by subject matter experts for accuracy
Rationales cite current nursing textbooks and evidence-based guidelines
Covers all major content areas weighted per ATI specifications
Includes updated pharmacology and diagnostic test information
Content Area Overview:
Content Area Questions Key Topics Weight
Urinary Elimination 1-60 Anatomy of urinary system, urinalysis, 24%
urinary tract infections, incontinence,
catheterization
Bowel Elimination 61-120 Constipation, diarrhea, bowel diversion 24%
(colostomy/ileostomy), bowel training,
laxatives
Renal Function and 121-170 Acute/chronic renal failure, BUN/creatinine, 20%
Fluid/Electrolyte Balance fluid volume deficit/excess, electrolyte
imbalances
Pharmacology for Elimination 171-210 Diuretics, anticholinergics, laxatives, stool 16%
softeners, antibiotics for UTIs
Diagnostic Tests and Procedures 211-240 Cystoscopy, urodynamic studies, KUB, 12%
renal ultrasound, bowel imaging
Patient Education and Nursing 241-250 Promoting normal elimination, preventing 4%
Interventions complications, discharge teaching
Page 2
,Q1. A patient with a history of recurrent urinary tract infections (UTIs) is prescribed a prophylactic
antibiotic. Which of the following mechanisms best explains why nitrofurantoin is preferred over
trimethoprim-sulfamethoxazole for long-term prophylaxis in this population, considering the impact on gut
and vaginal flora?
A. Nitrofurantoin achieves high urinary concentrations but minimal systemic absorption, reducing disruption of
normal microbiota.
B. Trimethoprim-sulfamethoxazole has a longer half-life, requiring less frequent dosing, which improves
adherence.
C. Nitrofurantoin is more effective against gram-negative bacteria, the most common cause of UTIs.
D. Trimethoprim-sulfamethoxazole is associated with a higher risk of Clostridioides difficile infection due to
broader spectrum activity.
Correct Answer: A. Nitrofurantoin achieves high urinary concentrations but minimal systemic absorption,
reducing disruption of normal microbiota.
Rationale: Nitrofurantoin is well-absorbed orally but rapidly excreted into urine, achieving high urinary
concentrations with low tissue levels; this minimizes disruption of gut and vaginal flora, reducing the risk of
secondary infections like candidiasis and C. difficile. Trimethoprim-sulfamethoxazole, while effective, has broader
systemic absorption and can alter normal flora, increasing resistance and adverse effects. Option A directly
addresses the key pharmacological advantage for prophylaxis.
Why Wrong:
B - While TMP-SMX has a longer half-life, this does not mitigate its impact on flora; adherence is not the
primary concern for prophylaxis.
C - Nitrofurantoin is effective against many gram-negative and some gram-positive organisms, but its
advantage is not solely based on spectrum; both drugs cover common uropathogens.
D - C. difficile risk is a concern with many antibiotics, but TMP-SMX is not the highest risk; the main reason
for preferring nitrofurantoin is its pharmacokinetic profile, not avoidance of C. difficile specifically.
Reference: Lehne, R.A. (2026). Pharmacology for Nursing Care, 12th Ed., Ch. 82
Q2. In a patient with chronic kidney disease (CKD) stage 4 and hyperphosphatemia, which of the following
phosphate binder combinations would be most appropriate, considering the patient's serum calcium level of
9.0 mg/dL (normal 8.5-10.5) and intact parathyroid hormone (iPTH) of 300 pg/mL (normal 10-65)?
A. Calcium carbonate alone, because the serum calcium is normal and calcium-based binders are most
effective.
B. Sevelamer carbonate alone, because it avoids calcium loading and has additional lipid-lowering effects.
C. Lanthanum carbonate alone, because it is the most potent binder and does not require multiple tablets.
D. A combination of calcium acetate and sevelamer carbonate, to achieve target phosphate while minimizing
calcium load.
Correct Answer: D. A combination of calcium acetate and sevelamer carbonate, to achieve target phosphate
while minimizing calcium load.
Rationale: In CKD stage 4 with hyperphosphatemia and elevated iPTH, the goal is to reduce phosphate without
inducing hypercalcemia (which could suppress PTH excessively) or worsening vascular calcification.
Calcium-based binders are effective but can cause calcium overload; non-calcium binders like sevelamer avoid
this. Combining a calcium-based binder (e.g., calcium acetate) with sevelamer allows lower doses of each,
achieving phosphate control while limiting calcium intake. Lanthanum is potent but expensive and carries risk of
accumulation; monotherapy with any single agent may require high doses. Option D represents a balanced,
guideline-recommended approach.
Why Wrong:
B - Sevelamer alone may require high pill burden and does not provide calcium for patients with low calcium;
the patient's calcium is normal, but adding a calcium binder can help achieve phosphate targets with fewer
pills.
Page 3
, C - Lanthanum is effective but not first-line due to cost and long-term safety concerns; combination therapy is
often preferred.
Reference: KDOQI Clinical Practice Guidelines for Bone Metabolism and Disease in CKD (2023)
Q3. A patient with neurogenic bladder due to spinal cord injury is started on clean intermittent
catheterization (CIC). Which of the following interventions is most critical to prevent autonomic dysreflexia
during catheterization?
A. Use a smaller catheter size (10-12 Fr) to minimize urethral trauma.
B. Instill 2% lidocaine gel into the urethra 5 minutes before catheterization.
C. Ensure the bladder is drained completely and slowly to avoid rapid decompression.
D. Perform catheterization at scheduled times to maintain bladder capacity.
Correct Answer: B. Instill 2% lidocaine gel into the urethra 5 minutes before catheterization.
Rationale: Autonomic dysreflexia (AD) is a life-threatening condition in patients with spinal cord injury above T6,
triggered by noxious stimuli below the level of injury, such as urethral distention or catheter insertion. Lidocaine
gel provides topical anesthesia, reducing afferent stimulation and preventing the reflex sympathetic surge. Smaller
catheters reduce trauma but do not eliminate the risk; slow drainage prevents hypotension but not AD; scheduled
catheterization helps with bladder management but does not directly prevent AD.
Why Wrong:
A - Smaller catheters reduce trauma but do not anesthetize the urethra; AD can still be triggered.
C - Rapid decompression can cause hypotension, not AD; AD is characterized by hypertension.
D - Scheduled CIC is important for bladder health but does not prevent AD; anesthesia is key.
Reference: Consortium for Spinal Cord Medicine. (2021). Clinical Practice Guideline: Management of Autonomic
Dysreflexia.
Q4. Which of the following laboratory findings is most consistent with prerenal acute kidney injury (AKI) as
opposed to intrinsic renal AKI due to acute tubular necrosis (ATN)?
A. Urine sodium < 20 mEq/L and fractional excretion of sodium (FeNa) < 1%.
B. Urine osmolality < 350 mOsm/kg and urine sediment with muddy brown casts.
C. Serum BUN:creatinine ratio < 10:1 and urine specific gravity < 1.010.
D. Fractional excretion of urea (FeUrea) < 35% and urine sodium > 40 mEq/L.
Correct Answer: A. Urine sodium < 20 mEq/L and fractional excretion of sodium (FeNa) < 1%.
Rationale: Prerenal AKI results from decreased renal perfusion, leading to intact tubular function that avidly
reabsorbs sodium and water, resulting in low urine sodium (<20 mEq/L) and low FeNa (<1%). In ATN, tubular
damage impairs reabsorption, causing higher urine sodium (>40 mEq/L) and FeNa >2%. Option A is classic for
prerenal. Option B describes ATN (muddy brown casts, low osmolality). Option C suggests intrinsic disease.
Option D (low FeUrea <35%) can be seen in prerenal, but high urine sodium contradicts prerenal.
Why Wrong:
B - Muddy brown casts and low urine osmolality are characteristic of ATN, not prerenal.
C - Low BUN:creatinine ratio and low specific gravity suggest intrinsic renal disease, not prerenal.
D - FeUrea <35% can occur in prerenal, but urine sodium >40 mEq/L is more consistent with ATN; this
combination is atypical.
Reference: KDIGO Clinical Practice Guideline for Acute Kidney Injury (2022)
Q5. A patient with cirrhosis and ascites is being evaluated for spontaneous bacterial peritonitis (SBP). A
diagnostic paracentesis reveals a polymorphonuclear neutrophil (PMN) count of 350 cells/mm³. Which of the
following is the most appropriate next step in management?
A. Start empiric antibiotic therapy with cefotaxime and intravenous albumin.
B. Repeat paracentesis in 48 hours to confirm the diagnosis before starting antibiotics.
C. Obtain blood cultures and start empiric antibiotic therapy with ceftriaxone alone.
Page 4
